"Dietary Supplement" identifier in labeling may be varied to include ingredient name.
This article was originally published in The Tan Sheet
Executive Summary"DIETARY SUPPLEMENT" IDENTIFIER IN LABELING MAY BE VARIED by including the name of a dietary ingredient or ingredients, such as "Vitamin C Supplement," FDA says in a Sept. 23 final rule on dietary supplement labeling. The agency also will allow use of an identifying term that describes the types of dietary ingredients contained in the product in "appropriately descriptive terms," such as "Multivitamin Supplement" or "Herbal Supplement.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.